Skip to content
← Full study record

NCT05061095 · FLOW

Participant flow

Understanding What Matters Most to Patients: Establishing the Validity of a Best-Worst Scaling Survey · Source last updated 2024-12-27

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups
  1. description
    Participants who consented to participate.
    id
    FG000
    title
    All Participants
periods
  1. milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        51
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        27
      type
      Enrolled and Registered
    3. achievements
      1. group Id
        FG000
        num Subjects
        19
      type
      COMPLETED
    4. achievements
      1. group Id
        FG000
        num Subjects
        32
      type
      NOT COMPLETED
    title
    Overall Study
pre Assignment Details
A total of fifty-one participants consented and were eligible for the study, but twenty-seven of them started the study interventions.
recruitment Details
Participants were recruited from 03/21/2022 through 06/29/2023 at one cancer center, in North Carolina. Subjects were enrolled in the study between 03/31/2022 through 06/29/2023.
Complete source fields
groups
  1. description
    Participants who consented to participate.
    id
    FG000
    title
    All Participants
periods
  1. milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        51
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        27
      type
      Enrolled and Registered
    3. achievements
      1. group Id
        FG000
        num Subjects
        19
      type
      COMPLETED
    4. achievements
      1. group Id
        FG000
        num Subjects
        32
      type
      NOT COMPLETED
    title
    Overall Study
pre Assignment Details
A total of fifty-one participants consented and were eligible for the study, but twenty-seven of them started the study interventions.
recruitment Details
Participants were recruited from 03/21/2022 through 06/29/2023 at one cancer center, in North Carolina. Subjects were enrolled in the study between 03/31/2022 through 06/29/2023.

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice